Showing results (151-160 of 196) with videos related to
Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Piperazinedione, total body irradiation, and autologous bone marrow transplantation in chronic myelogenous leukemiaL Vellekoop, A R Zander, H M Kantarjian, et al.Annals of Hematology|May 3, 2003
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemiaN Kröger, M Bornhäuser, G Ehninger, et al.Leukemia|November 5, 2004
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioningA Shimoni, N Kröger, T Zabelina, et al.Bone Marrow Transplantation|May 1, 2012
Evaluation of BM cytomorphology after allo-SCT in patients with AMLM Christopeit, K Miersch, E Klyuchnikov, et al.Bone Marrow Transplantation|July 23, 1998
Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapyN Kröger, M Hoffknecht, M Hänel, et al.Experimental Hematology|January 1, 1979
Autologous bone marrow transplantation in relapsed adult acute leukemiaK A Dicke, A R Zander, G Spitzer, et al.Free Radical Biology & Medicine|May 10, 2000
Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantationM Dürken, C Herrnring, B Finckh, et al.British Journal of Haematology|July 10, 2001
Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion with anti-thymocyte globulinN Kröger, T Zabelina, W Krüger, et al.Bone Marrow Transplantation|May 1, 1996
Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testisW Zeller, K Gutensohn, M Stockschläder, et al.Transfusion|January 1, 1984
Rescue by peripheral blood mononuclear cells in dogs from bone marrow failure after total-body irradiationA R Zander, K N Gray, J P Hester, et al.Pageof 20